> Two Indian states halted off-label use of Roche's ($RHHBY) Avastin for vision conditions after more than a dozen patients underwent surgery for pain and swelling in their eyes. Report

> The Danish enzyme maker Novozymes separated its biopharma activities into an independent company called Albumedix. Report

> Merck KGaA tapped two new members for its executive board, Udit Batra, who heads up its life science business recently enlarged with its Sigma-Aldrich buyout; and Walter Galinat, who heads up performance materials. Release

> Aurobindo Pharma won FDA approval for its version of the Pfizer ($PFE) clotting drug Cyklokapron (tranexamic acid). Report